BCIQ Profiles

Company Profile Report
0420 Forbion
BioCentury & Getty Images

Finance

With upsized opportunity fund closing at €360M, Forbion readies to build on portfolio with three-pronged strategy 

Forbion is carving out a strategy that’s differentiated from most biotech opportunity funds

Forbion is carving out a strategy that’s differentiated from most biotech opportunity funds with support from a team of advisers that’s a who’s who of European CEOs.

Read the full 610 word article

How to gain access

Continue reading with a
two-week free trial.